Gilead Sciences, Inc.

(NASDAQ Global Select)
Back to all articles
Bullish +75

Gilead Sciences (NASDAQ:GILD): A Value Screen Candidate with Strong Profitability - ChartMill

AI-generated analysis

πŸ” Gilead Sciences (NASDAQ:GILD) was identified as a potential value investing candidate using ChartMill's methodical screening process.

πŸ’° The company receives a Valuation Mark of 7 out of 10, suggesting it is priced lower than comparable peers in the biopharmaceutical sector.

πŸ›οΈ Gilead demonstrates a Financial Health Mark of 6, indicating firm but varied liquidity and solvency suitable for long-term stability.

πŸ’ͺ Profitability analysis yields a high Mark of 8, highlighting strong margins and returns on capital that provide a margin of safety.

πŸ“ˆ Growth prospects are marked with a score of 5, reflecting steady rather than rapid expansion expected to support future re-rating.

πŸ“‰ The stock trades at a notable discount relative to both market and industry averages based on earnings and cash flow multiples.

πŸ›‘οΈ Despite minor liquidity notes, the company's overall solvency is described as firm, mitigating risks associated with its low valuation.

πŸ€” Analysis concludes that Gilead presents more than a basic "value trap" due to its combination of low price and high profitability.

πŸ“‹ The stock qualifies for ChartMill's High ROIC Stocks screen due to strong returns on invested capital.

πŸ’΅ Gilead is included in the High Free Cash Flow Stocks list, generating strong cash flows relative to its current price.

πŸ† It appears on the Best Dividend Stocks screen, indicating a high and sustainable dividend payout.

βœ… The company also meets the criteria for the Safe Dividends Stock Screen, combining high dividends with financial health.

⚠️ Investors are advised that past results do not guarantee future performance and should conduct their own research.

πŸ”— ChartMill offers an additional screening tool that investors can use to find other stocks matching this "Acceptable Value" profile.

⏱️ The data for this analysis is current as of April 24, 2026.

πŸ“Œ Gilead Sciences is positioned as a fundamentally good business that the market may currently be undervaluing.

Bullish Signals
  • Gilead Sciences (NASDAQ:GILD) received a Valuation Mark of 7 out of 10, indicating the market may be pricing the company lower than its intrinsic value.
  • The company achieved an excellent Profitability Mark of 8, demonstrating strong inherent earning ability and providing a 'margin of safety' for value investors.
  • Gilead is currently listed in the High ROIC Stocks screen on ChartMill, confirming it generates strong returns on invested capital.
  • The stock is part of the High Free Cash Flow Stocks screen, indicating it produces robust cash flows relative to its current price.
  • Gilead appears on the Best Dividend Stocks and Safe Dividends Stock Screen lists, signifying it offers a high and sustainable dividend alongside financial health.
  • Management maintains firm solvency despite minor liquidity notes, ensuring the company can navigate market periods effectively.
  • Earnings expansion estimates are described as positive and speeding up, suggesting potential for future re-rating in the market.
Risk Factors
  • The Financial Health Mark of 6 indicates a 'mostly firm but varied' situation, suggesting potential liquidity concerns that could undermine long-term stability.
  • Growth Mark of 5 reflects steady expansion that is described as 'not amazing,' which may limit the stock's ability to significantly re-rate or outperform peers.
  • While profitability is strong with a mark of 8, the article acknowledges that pure value stocks often lack fast expansion, creating a growth ceiling for investors.
  • The disclaimer explicitly states that past results are not a guide to future results, highlighting the inherent risk that current fundamental marks may not predict future performance.
  • Investors are urged to 'do their own study and talk with a qualified financial advisor,' implying significant uncertainty in the valuation assessment that requires external validation.
Full Analysis
Gilead Sciences Inc (NASDAQ:GILD) has emerged as a candidate for investors utilizing a systematic value screening process that seeks stocks where market price may not fully reflect underlying business value. The analysis indicates Gilead sells at a notable discount to both the broader market and its industry peers based on standard earnings and cash flow multiples, while maintaining strong profitability metrics that provide a margin of safety. According to ChartMill's fundamental study, the company has received a Valuation Mark of 7 out of 10, placing it in a favorable position relative to similar companies, with specific attention paid to distinguishing potential value traps from opportunities where high-quality businesses are temporarily undervalued. The assessment breaks down the company's fundamentals into four key areas: valuation, financial health, profitability, and growth. Gilead demonstrates a Financial Health Mark of 6, which reflects a mostly firm but varied situation that suggests its low valuation likely stems from market sentiment rather than deeper structural risks. Profitability is rated highly with a Mark of 8, driven by field-leading returns on capital and firm margins that support long-term value. Growth is assessed with a Mark of 5, indicating a steady, though not exceptional, expansion path that aligns with the expectation that pure value stocks may not exhibit rapid growth but require moderate expansion to eventually trigger a market re-rating. Beyond these specific marks, Gilead currently appears in multiple ChartMill screener lists, highlighting its inclusion in High ROIC Stocks, High Free Cash Flow Stocks, Best Dividend Stocks, and Safe Dividends Stock Screen categories. The article notes that while liquidity shows some minor concerns within the financial health assessment, overall solvency remains firm. The combination of low price, strong profits, acceptable health, and steady expansion makes Gilead a notable example of the type of opportunity value investing screens aim to uncover. It represents a fundamentally sound business that the market may be undervaluing at this time, supported by accelerating earnings estimates rather than being trapped by lasting problems.